No preview available from this publisher — open the full story below.
Indian drugmakers are intensely competing to develop biosimilars for Keytruda, a leading cancer drug. This strategic race is driven by the significant market potential and the opportunity to provide more affordable treatment options globally. Success in this venture could…
Market Samachar is a news aggregator. This article was originally published by indian-share-tips.com. Tap the button above to read the full story on their site.